人工血管市場-世界の産業規模、シェア、動向、機会、予測、製品別、用途別、地域別、競合別、2020年～2030年

人工血管の世界市場は2024年に12億9,000万米ドルとなり、予測期間中にCAGR7.31％で成長し、2030年までには19億7,000万米ドルに達すると予測されています。

同市場は、主に末梢動脈疾患（PAD）、動脈瘤、冠動脈疾患（CAD）などの血管障害の有病率の増加により、力強い成長を遂げています。血管の狭窄や閉塞を伴うこれらの疾患は、脳卒中、心筋梗塞、四肢虚血などの重大な合併症を引き起こす可能性があり、人工血管を用いた外科的介入が必要となります。さらに、冠動脈バイパス移植術（CABG）や血管内動脈瘤修復術（EVAR）のような手技の件数が増加していることも、需要をさらに後押ししています。人工血管は、損傷した血管を置き換えたりバイパスしたりすることで、これらの手術において重要な役割を果たしています。技術の進歩や製品の革新も市場を前進させています。例えば、2022年5月、UC Davisは、血液透析患者のための次世代人工血管を開発するために、California Institute for Regenerative Medicineから300万米ドルの助成金を受け取りました。このような開発は、移植片の性能と寿命の向上に対する利害関係者の継続的なコミットメントを反映したものであり、今後数年間の市場開拓を大きく後押しするものと期待されます。

主要な市場促進要因

心血管疾患の有病率の増加

主要な市場課題

厳しい規制

主要市場動向

技術の進歩

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の人工血管市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（血液透析アクセスグラフト、血管内ステントグラフト、末梢血管グラフト、冠動脈バイパスグラフト）
  • 用途別（動脈瘤、腎不全、血管閉塞、冠動脈疾患、その他の用途）
  • 企業別（2024年）
  • 地域別
• 市場マップ

第6章 北米の人工血管市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の人工血管市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の人工血管市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の人工血管市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの人工血管市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Abbott Laboratories
• Braun Melsungen AG
• Becton, Dickinson and Company（Bard Peripheral Vascular Inc.）
• Cardinal Health（Cordis Corporation）
• Cook Medical
• Endologix Inc.
• Getinge Group
• LeMaitre Vascular Inc.
• Medtronic PLC
• Terumo Medical Corporation.

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Vascular Graft Market was valued at USD 1.29 Billion in 2024 and is anticipated to reach USD 1.97 Billion by 2030, growing at a CAGR of 7.31% during the forecast period. The market is witnessing strong growth, primarily due to the increasing prevalence of vascular disorders such as peripheral artery disease (PAD), aneurysms, and coronary artery disease (CAD). These conditions, which involve the narrowing or blockage of blood vessels, can lead to critical complications like stroke, myocardial infarction, and limb ischemia, thereby necessitating surgical interventions using vascular grafts. Additionally, the rising volume of procedures such as coronary artery bypass grafting (CABG) and endovascular aneurysm repair (EVAR) has further supported demand. Vascular grafts play a crucial role in these surgeries by replacing or bypassing damaged blood vessels. Technological progress and product innovation are also advancing the market. For example, in May 2022, UC Davis received a USD 3 million grant from the California Institute for Regenerative Medicine to develop a next-generation vascular graft for hemodialysis patients. Such developments reflect the ongoing commitment of stakeholders to enhance the performance and longevity of grafts, which is expected to significantly boost market growth in the coming years.

Key Market Drivers

Increasing Prevalence of Cardiovascular Diseases

The global vascular graft market is primarily driven by the escalating incidence of cardiovascular conditions such as coronary artery disease, peripheral arterial disease, and aortic aneurysms. These diseases represent a growing health concern worldwide, largely attributed to sedentary lifestyles, unhealthy diets, and an aging population. As more individuals develop comorbidities like hypertension, diabetes, and obesity, the risk of cardiovascular events increases, fueling the need for surgical interventions involving vascular grafts. This surge in disease burden directly correlates with rising demand for procedures like CABG and EVAR, where vascular grafts are essential for restoring adequate blood flow. As a result, the demand for graft-based solutions is set to grow steadily, supporting overall market expansion.

Key Market Challenges

Stringent Regulatory Hurdles

A significant challenge in the vascular graft market lies in the rigorous regulatory landscape governing medical devices. Organizations such as the U.S. FDA and EMA mandate thorough evaluations to ensure the safety and efficacy of vascular grafts, including extensive clinical trials and quality testing. While such standards are crucial for safeguarding public health, they contribute to extended development timelines and higher compliance costs. This can be particularly burdensome for smaller firms with limited resources, ultimately restricting the pace of innovation and delaying patient access to new products. Additionally, the need to navigate varying regulatory frameworks across different countries complicates global product approvals and increases market entry barriers for manufacturers.

Key Market Trends

Technological Advancements

Continuous innovation in graft materials and design is a key trend shaping the vascular graft market. Advanced materials, such as bioengineered and tissue-engineered grafts, have significantly enhanced the safety and performance of these products by improving biocompatibility and reducing the risk of complications. Furthermore, grafts featuring anti-thrombogenic and anti-infective coatings are gaining traction, offering better outcomes in terms of long-term patency and infection prevention. These developments not only improve surgical success rates but also enable wider application of vascular grafts in complex procedures. As technologies evolve, next-generation grafts are expected to play a more prominent role in vascular surgeries, encouraging wider clinical adoption and contributing to market growth.

Key Market Players

• Abbott Laboratories
• Braun Melsungen AG
• Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
• Cardinal Health (Cordis Corporation)
• Cook Medical
• Endologix Inc.
• Getinge Group
• LeMaitre Vascular Inc.
• Medtronic PLC
• Terumo Medical Corporation

Report Scope:

In this report, the Global Vascular Graft Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vascular Graft Market, By Product:

• Hemodialysis Access Graft Endovascular Stent Graft
• Peripheral Vascular Graft
• Coronary Artery By-pass Graft

Vascular Graft Market, By Drug Application:

• Aneurysms
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Diseases
• Other Applications

Vascular Graft Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vascular Graft Market.

Available Customizations:

Global Vascular Graft Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vascular Graft Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-pass Graft)
  • 5.2.2. By Application (Aneurysms, Kidney Failure, Vascular Occlusion, Coronary Artery Diseases, Other Applications)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Vascular Graft Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vascular Graft Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Vascular Graft Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Vascular Graft Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Vascular Graft Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Vascular Graft Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Vascular Graft Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Vascular Graft Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Vascular Graft Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Vascular Graft Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia-Pacific Vascular Graft Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Vascular Graft Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Vascular Graft Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Vascular Graft Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Vascular Graft Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Vascular Graft Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. South America Vascular Graft Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Vascular Graft Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Vascular Graft Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Vascular Graft Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Middle East and Africa Vascular Graft Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Vascular Graft Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Vascular Graft Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Vascular Graft Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Braun Melsungen AG
• 15.3. Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
• 15.4. Cardinal Health (Cordis Corporation)
• 15.5. Cook Medical
• 15.6. Endologix Inc.
• 15.7. Getinge Group
• 15.8. LeMaitre Vascular Inc.
• 15.9. Medtronic PLC
• 15.10. Terumo Medical Corporation.

16. Strategic Recommendation

17. About Us & Disclaimer